Core Viewpoint - Sino Medical achieved a significant stock price increase of 19.99% on August 18, reaching a price of 41.48 CNY per share, with a trading volume of 2.032 billion CNY and a turnover rate of 12.37%, resulting in a total market capitalization of 17.258 billion CNY [1] Company Overview - Sino Medical Technology Co., Ltd. is located in the Tianjin Economic-Technological Development Area and specializes in the research, production, and sales of high-end interventional medical devices [1] - The company’s main products include coronary drug-eluting stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents, with over 1.4 million units used globally, serving hundreds of thousands of patients [1] - Sino Medical holds 8 key technologies, has launched 19 products, and possesses over 200 global patents, while undertaking 7 national and provincial scientific research projects [1] - Clinical research results of its products have been published in 31 articles in core domestic and international journals [1] Financial Performance - For the period from January to March 2025, Sino Medical reported a revenue of 101 million CNY, representing a year-on-year growth of 10.75% [1] - The net profit attributable to shareholders was 2.9693 million CNY, showing a substantial year-on-year increase of 277.50% [1] - As of March 31, the number of shareholders was 11,000, with an average of 37,400 circulating shares per person [1]

8月13日，赛诺医疗盘中19.99%涨停，截至14:19，报30.13元/股，成交30.05亿元，换手率26.34%，总市 值125.36亿元。 资料显示，赛诺医疗科学技术股份有限公司位于天津开发区第四大街5号泰达生物医药研发大厦B区2 层，公司是一家专注于高端介入医疗器械研发、生产、销售的国际化公司，主营产品包括冠脉药物支 架、冠脉球囊、颅内快速交换球囊、颅内药物洗脱支架等，累计使用超过140万个，服务于全球数十万 患者。公司拥有8项关键技术，已上市产品19款，全球专利数200余件，承担国家级、省级科研项目7 项，产品临床研究结果已在国内国际核心期刊发表31篇。 截至3月31日，赛诺医疗股东户数1.1万，人均流通股3.74万股。 2025年1月-3月，赛诺医疗实现营业收入1.01亿元，同比增长10.75%；归属净利润296.93万元，同比增长 277.50%。 来源：金融界 ...

证券代码：688108 证券简称：赛诺医疗 赛诺医疗科学技术股份有限公司 赛诺医疗科学技术股份有限公司 为保障赛诺医疗科学技术股份有限公司（以下简称"公司"）全体股东的合法权益，维护 股东大会的正常秩序，保证股东大会的议事效率，确保本次股东大会如期、顺利召开，根据《中 华人民共和国公司法》 《赛诺医疗科学技术股份有限公司章程》 《赛诺医疗科学技术股份有限公 司股东大会议事规则》及中国证监会、上海证券交易所的有关规定，特制定本须知。 一、股东大会设会务组，由公司董事会秘书负责会议的程序安排和会务工作。 二、为保证股东大会的严肃性和正常秩序，切实维护与会股东及股东代理人的合法权益， 除出席会议的股东及股东代理人、公司董事、监事、高级管理人员、见证律师及董事会邀请的 人员外，公司有权依法拒绝其他人员进入会场。 三、出席现场会议的股东及股东代理人须在会议召开前半小时到达会议现场办理签到手续， 并请按规定出示证券账户卡、身份证明文件或营业执照/注册证书复印件（加盖公章）、授权委 托书以及参会回执等，上述登记材料均需要提供复印件一份，个人登记材料复印件须个人签字， 法定代表人证明文件复印件须公司盖章，经验证后领取会议资料 ...